Frontiers in Endocrinology·26 SepExercise-responsive endocrine-metabolic mediators in diabetes and cardiometabolic disorders: a systematic scoping review and evidence mapSystematic reviewMechanismsPaper
ADA Scientific Sessions 2025 Abstract·13 JunTargeting Activin Type II Receptors—Develop Monoclonal Antibodies LAE102, LAE103, and LAE123 as Candidate Therapeutics for Muscle Growth and Fat ReductionExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunFirst-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LAE102 in Healthy VolunteersTrial in peopleInterventionsPaper